Gene · 7130
Papers2,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Multipotent Mesenchymal Cells Homing and Differentiation on Poly(ε-caprolactone) Blended with 20% Tricalcium Phosphate and Polylactic Acid Incorporating 10% Hydroxyapatite 3D-Printed Scaffolds via a Commercial Fused Deposition Modeling 3D Device. | Biology (Basel) | 2023 | 38132300 | PubTator, text mining | PubMed |
| Recent advances in polymeric microparticle-based drug delivery systems for knee osteoarthritis treatment. | Front Bioeng Biotechnol | 2023 | 38130826 | PubTator, text mining | PubMed |
| Age-related changes in human bone marrow mesenchymal stromal cells: morphology, gene expression profile, immunomodulatory activity and miRNA expression. | Front Immunol | 2023 | 38130717 | PubTator, text mining | PubMed |
| Amniotic MSC affect CD8 naive polarization toward SLEC/MPEC subsets by down-modulating IL-12Rβ1 and IL-2Rα signaling pathways. | iScience | 2023 | 38077154 | PubTator, text mining | PubMed |
| The Pivotal Role of Nrf2 Signal Axis in Intervertebral Disc Degeneration. | J Inflamm Res | 2023 | 38076332 | PubTator, text mining | PubMed |
| Comparison of the Therapeutic Effects of Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells on Renal Fibrosis. | Int J Mol Sci | 2023 | 38069242 | PubTator, text mining | PubMed |
| Loss of Uncoupling Protein 1 Expression in the Subcutaneous Adipose Tissue Predicts Childhood Obesity. | Int J Mol Sci | 2023 | 38069028 | PubTator, text mining | PubMed |
| Hypoxia and inflammatory factor preconditioning enhances the immunosuppressive properties of human umbilical cord mesenchymal stem cells. | World J Stem Cells | 2023 | 38058960 | PubTator, text mining | PubMed |
| Young infants display heterogeneous serological responses and extensive but reversible transcriptional changes following initial immunizations. | Nat Commun | 2023 | 38042900 | PubTator, text mining | PubMed |
| The effect of TLR3 priming conditions on MSC immunosuppressive properties. | Stem Cell Res Ther | 2023 | 38031182 | PubTator, text mining | PubMed |
| Revolutionizing orofacial pain management: the promising potential of stem cell therapy. | Front Pain Res (Lausanne) | 2023 | 38028430 | PubTator, text mining | PubMed |
| ApoSEVs-Mediated Modulation of Versatile Target Cells Promotes Diabetic Wound Healing: Unveiling a Promising Strategy. | Int J Nanomedicine | 2023 | 38026535 | PubTator, text mining | PubMed |
| The role of primed and non-primed MSC-derived conditioned media in neuroregeneration. | Front Mol Neurosci | 2023 | 38025267 | PubTator, text mining | PubMed |
| Prospective therapeutics for intestinal and hepatic fibrosis. | Bioeng Transl Med | 2023 | 38023697 | PubTator, text mining | PubMed |
| The SYSCID map: a graphical and computational resource of molecular mechanisms across rheumatoid arthritis, systemic lupus erythematosus and inflammatory bowel disease. | Front Immunol | 2023 | 38022524 | PubTator, text mining | PubMed |
| A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size. | PLoS Pathog | 2023 | 38019897 | PubTator, text mining | PubMed |
| Nanoparticles and Mesenchymal Stem Cell (MSC) Therapy for Cancer Treatment: Focus on Nanocarriers and a si-RNA CXCR4 Chemokine Blocker as Strategies for Tumor Eradication In Vitro and In Vivo. | Micromachines (Basel) | 2023 | 38004925 | PubTator, text mining | PubMed |
| Advanced Progress in the Role of Adipose-Derived Mesenchymal Stromal/Stem Cells in the Application of Central Nervous System Disorders. | Pharmaceutics | 2023 | 38004615 | PubTator, text mining | PubMed |
| Treatment of Scleroderma-Related Microstomia Using Hyaluronic Acid: An Interventional Study. | Life (Basel) | 2023 | 38004316 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 38003482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7130/papers?page=11